BEGIN:VCALENDAR
PRODID:Vermont Department of Health
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0500
END:STANDARD
END:VTIMEZONE
VERSION:2.0
BEGIN:VEVENT
UID:dea3870f-3e53-4eb7-b1ee-23ac9714d03f
SUMMARY:Buprenorphine 101
DTSTAMP:20261119T213000Z
DTSTART;TZID=America/New_York:20260123T130000
DTEND;TZID=America/New_York:20260123T140000
DESCRIPTION:Buprenorphine 101This training is designed to provide foundational knowledge and skills in initiating buprenorphine treatment for opioid use disorder in the outpatient setting in the context of the widespread presence of illicitly manufactured fentanyl. We explore how the potency and prevalence of fentanyl complicates the initiation phase of buprenorphine treatment, leading to potential clinical challenges such as precipitated withdrawal. We suggest participating in the next training in the series, Buprenorphine 201, upon completing Buprenorphine 101.Learn more and registerFor trainings that indicate Continuing Education Units (CEUs) are available, contact your licensing or certification organization to verify that the credits will count toward the continuing education requirements.
LOCATION:Virtual
END:VEVENT
END:VCALENDAR